Technical Analysis for TSVT - 2seventy bio, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 4.40 | 1.38% | 0.06 |
TSVT closed up 1.38 percent on Friday, November 1, 2024, on 62 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Nov 12
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Doji - Bullish? | Reversal | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| MACD Bearish Centerline Cross | Bearish | 1.38% | |
| Stochastic Reached Oversold | Weakness | 1.38% | |
| BB Squeeze Ended | Range Expansion | 1.38% | |
| Below Lower BB | Weakness | 1.38% | |
| Down 3 Days in a Row | Weakness | 1.38% |
| Alert | Time |
|---|---|
| Up 5% | about 20 hours ago |
| Rose Above Lower Bollinger Band | about 23 hours ago |
| Up 3% | about 23 hours ago |
| Up 2% | about 23 hours ago |
| Up 1% | about 24 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/12/2024
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts. 2seventy bio, Inc. operates independently of bluebird bio, Inc. as of November 4, 2021.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Life Sciences Gene Therapy Multiple Myeloma Breakthrough Therapy Chimeric Antigen Receptor T Cell
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Life Sciences Gene Therapy Multiple Myeloma Breakthrough Therapy Chimeric Antigen Receptor T Cell
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 6.4 |
| 52 Week Low | 1.535 |
| Average Volume | 277,453 |
| 200-Day Moving Average | 4.65 |
| 50-Day Moving Average | 4.75 |
| 20-Day Moving Average | 4.87 |
| 10-Day Moving Average | 4.81 |
| Average True Range | 0.24 |
| RSI (14) | 38.27 |
| ADX | 19.63 |
| +DI | 14.93 |
| -DI | 22.81 |
| Chandelier Exit (Long, 3 ATRs) | 4.57 |
| Chandelier Exit (Short, 3 ATRs) | 5.07 |
| Upper Bollinger Bands | 5.28 |
| Lower Bollinger Band | 4.45 |
| Percent B (%b) | -0.06 |
| BandWidth | 17.23 |
| MACD Line | -0.05 |
| MACD Signal Line | 0.03 |
| MACD Histogram | -0.0809 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.75 | ||||
| Resistance 3 (R3) | 4.76 | 4.67 | 4.69 | ||
| Resistance 2 (R2) | 4.67 | 4.58 | 4.66 | 4.67 | |
| Resistance 1 (R1) | 4.53 | 4.52 | 4.52 | 4.52 | 4.65 |
| Pivot Point | 4.44 | 4.44 | 4.43 | 4.43 | 4.44 |
| Support 1 (S1) | 4.30 | 4.35 | 4.29 | 4.29 | 4.15 |
| Support 2 (S2) | 4.21 | 4.29 | 4.20 | 4.13 | |
| Support 3 (S3) | 4.07 | 4.21 | 4.11 | ||
| Support 4 (S4) | 4.06 |
